Semiparametric analysis of non-steady-state pharmacodynamic data

We present an approach to the analysis of pharmacodynamic (PD) data arising from non-steadystate experiments, meant to be used when only PD data, not pharmacokinetic (PK) data, are available. The approach allows estimation of the steady-state relationship between drug input and effect. The analysis is based on a model describing the time dependence of drug effect (E) on (unobserved) drug concentration (Ce) in an hypothetical effect compartment. The model consists of (i) a known model for the input rate of drug I(t), (ii) a parametric model; L(t, a) (a function of time t, and vector of parameters a), relating I to an observed variable X, (iii) a nonparametric model relating X to E. Ce is proportional to X. X(t) is given by I(X) * L(t, a)/AL, where L(t,α)=e−α1t * ∑k=1m, α2ke−α2k+1t, ∑k=1m α2k=1, AL=∫0∞ L(t) dt, and * indicates convolution.The nonparametric model relating X to Eis a cubic spline, a function of X and a vector of (linear) parameters β. The values of α and β are chosen to minimize the sum of squared residuals between predicted and observed E. We also describe a similar model, generalizing a previously described one, to analyze PK/PD data. Applications of the approach to different drug-effect relationships (verapamil-PR interval, hydroxazine-wheal and flare, flecainide and/or verapamil-PR, and left ventricular ejection fraction) are reported.

[1]  L. Sheiner,et al.  Pharmacodynamic modeling of verapamil effects under steady-state and nonsteady-state conditions. , 1989, The Journal of pharmacology and experimental therapeutics.

[2]  R. Mcquinn,et al.  The pharmacodynamic and pharmacokinetic interaction between single doses of flecainide acetate and verapamil: Effects on cardiac function and drug clearance , 1989, Clinical pharmacology and therapeutics.

[3]  K. Simons,et al.  The pharmacokinetics and antihistaminic of the H1 receptor antagonist hydroxyzine. , 1984, The Journal of allergy and clinical immunology.

[4]  Carl de Boor,et al.  A Practical Guide to Splines , 1978, Applied Mathematical Sciences.

[5]  L B Sheiner,et al.  Simultaneous Modeling of Pharmacokinetics and Pharmacodynamics with a Nonparametric Pharmacodynamic Model , 1984, Clinical pharmacology and therapeutics.

[6]  G. Segre,et al.  Kinetics of interaction between drugs and biological systems. , 1968, Il Farmaco; edizione scientifica.

[7]  Lewis B. Sheiner,et al.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: an improved algorithm , 1987, Comput. Appl. Biosci..

[8]  Douglas M. Bates,et al.  Nonlinear Regression Analysis and Its Applications , 1988 .

[9]  A Sibbald,et al.  A pharmacodynamic model for pancuronium. , 1978, British journal of anaesthesia.

[10]  V. F. Smolen Theoretical and computational basis for drug bioavailability determinations using pharmacological data. I. General considerations and procedures , 1976, Journal of Pharmacokinetics and Biopharmaceutics.

[11]  H. Akaike A new look at the statistical model identification , 1974 .

[12]  Peter Veng-Pedersen,et al.  Estimation of amobarbital plasma-effect site equilibration kinetics. Relevance of polyexponential conductance functions , 1991, Journal of Pharmacokinetics and Biopharmaceutics.

[13]  L B Sheiner,et al.  Simultaneous modeling of pharmacokinetics and pharmacodynamics with nonparametric kinetic and dynamic models , 1986, Clinical pharmacology and therapeutics.

[14]  V. F. Smolen Theoretical and computational basis for drug bioavailability determinations using pharmacological data. II. Drug input ⇄ response relationships , 1976, Journal of Pharmacokinetics and Biopharmaceutics.

[15]  D. Campbell The use of kinetic-dynamic interactions in the evaluation of drugs , 2005, Psychopharmacology.

[16]  L. Sheiner Clinical pharmacology and the choice between theory and empiricism , 1989, Clinical pharmacology and therapeutics.

[17]  Lewis B. Sheiner,et al.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarine , 1979 .

[18]  P. Veng‐Pedersen,et al.  A system approach to pharmacodynamics. I: Theoretical framework. , 1988, Journal of pharmaceutical sciences.

[19]  L B Sheiner,et al.  Semiparametric approach to pharmacokinetic-pharmacodynamic data. , 1989, The American journal of physiology.

[20]  C. R. Deboor,et al.  A practical guide to splines , 1978 .

[21]  E. H. Twizell The mathematical modeling of metabolic and endocrine systems: E.R. Carson, C. Cobelli and L. Finkelstein John Wiley and Sons, Chichester, Sussex, UK, 394 pp., £45.15, 1983 , 1984 .

[22]  L B Sheiner,et al.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. , 1980, Clinical pharmacology and therapeutics.

[23]  M Danhof,et al.  A system approach to pharmacodynamics. III: An algorithm and computer program, COLAPS, for pharmacodynamic modeling. , 1991, Journal of pharmaceutical sciences.